Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-04
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Laminin (925-933): Defined ECM Peptide for Cell Adhesion ...

    2026-03-16

    Laminin (925-933): Defined ECM Peptide for Cell Adhesion and Migration Assays

    Executive Summary: Laminin (925-933) is a synthetic peptide corresponding to residues 925-933 of the laminin B1 chain, a crucial component of basement membranes. It modulates cell adhesion, migration, and chemotaxis in vitro at defined concentrations, enabling reproducible cell-based assays (APExBIO product page). The peptide binds specifically to the laminin receptor, competitively inhibiting chemotactic responses to full-length laminin. It is validated for use in cancer metastasis and neurobiology workflows, with evidence supporting its functional relevance in modulating extracellular matrix signaling (McGeachan et al., 2025). Laminin (925-933) is supplied as a solid, with defined solubility and storage parameters, ensuring experimental reproducibility.

    Biological Rationale

    Laminins are large extracellular matrix glycoproteins, with the B1 chain playing a key role in basement membrane structure and function. Basement membranes regulate cellular processes such as adhesion, migration, differentiation, and tissue integrity (McGeachan et al., 2025). The 925-933 region of the laminin B1 chain contains a functional cell attachment motif (Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg) that interacts with cell-surface laminin receptors. Synthetic peptides like Laminin (925-933) enable precise modulation of these interactions, facilitating controlled study of extracellular matrix (ECM) signaling pathways in vitro. This approach is essential for dissecting mechanisms of cancer metastasis, neurodegeneration, and tissue engineering, where reproducibility and specificity are critical (Laminin (925-933): A Defined Cell Adhesion Peptide for ECM Assays).

    Mechanism of Action of Laminin (925-933)

    Laminin (925-933) binds specifically to the 67-kDa laminin receptor on the cell surface (Laminin (925-933): Unraveling ECM Peptides in Advanced Cell Migration). This receptor interaction mimics a natural segment of full-length laminin, promoting cell attachment and chemotactic migration. The peptide acts as a competitive inhibitor, blocking full-length laminin from eliciting maximal chemotactic responses and thereby modulating cell migration dynamics. At concentrations of 100–300 µg/mL, Laminin (925-933) stimulates robust attachment of HT-1080 (human fibrosarcoma) and CHO (Chinese hamster ovary) cells. In B16F10 murine melanoma cells, it induces approximately 30% of the maximal chemotactic response observed with full-length laminin (Scenario-Driven Solutions in Cell Assays with Laminin (925-933)).

    Evidence & Benchmarks

    • Laminin (925-933) (100–300 µg/mL) stimulates HT-1080 and CHO cell attachment to tissue culture plates, confirming its role as a cell adhesion peptide (APExBIO).
    • In B16F10 murine melanoma cells, the peptide elicits ~30% of the maximal chemotactic response compared to full-length laminin, quantified in Boyden chamber assays (McGeachan et al., 2025).
    • Laminin (925-933) competitively inhibits chemotaxis toward full-length laminin, demonstrating functional specificity as a modulator of cell migration (Laminin (925-933): A Defined Cell Adhesion Peptide for ECM Assays).
    • Solubility is measured at ≥15.53 mg/mL in water, ≥17.77 mg/mL in ethanol, and ≥48.35 mg/mL in DMSO, supporting diverse assay formats (APExBIO).
    • The peptide is a solid with a molecular weight of 967.06 Da, stable at -20°C for long-term storage (product specifications).
    • It improves assay reproducibility and sensitivity, outperforming undefined ECM fragments in standard cell migration workflows (Scenario-Driven Solutions in Cell Assays with Laminin (925-933)).

    Applications, Limits & Misconceptions

    Laminin (925-933) is validated for use in:

    • Cell adhesion and migration assays using a range of cell lines (HT-1080, CHO, B16F10).
    • Cancer metastasis research, where inhibition or quantification of cell motility is required (Laminin (925-933): Precision Tools for Translational Research).
    • Neurobiology studies investigating ECM signaling and synaptic plasticity (McGeachan et al., 2025).
    • Basement membrane protein research, especially for dissecting receptor-ligand specificity.

    By using a chemically defined peptide, experimental reproducibility is enhanced compared to native ECM extracts. The A1023 kit from APExBIO ensures batch-to-batch consistency.

    Interlinking: While Laminin (925-933): A Defined Cell Adhesion Peptide for ECM Assays summarizes biochemical benchmarks, this article extends the discussion by integrating translational relevance and practical workflow parameters. See also Laminin (925-933): Precision Tools for Translational Research for a broader review of ECM signaling mechanisms; the current article emphasizes quantitative assay benchmarks and mechanistic specificity.

    Common Pitfalls or Misconceptions

    • Laminin (925-933) does not replicate all biological activities of full-length laminin; it primarily modulates cell adhesion and chemotaxis.
    • This peptide is not suitable as a direct substitute for complete ECM scaffolds in 3D culture or tissue engineering applications.
    • It is not intended for diagnostic or therapeutic use in humans or animals, per APExBIO's research-use-only policy.
    • Peptide activity is concentration-dependent; suboptimal dosing may yield variable results.
    • Long-term solution storage at room temperature leads to degradation and loss of function; short-term, low-temperature storage is mandatory.

    Workflow Integration & Parameters

    Laminin (925-933) integrates into standard cell-based assay workflows as a defined modulator of cell attachment and migration. Typical protocols use concentrations of 100–300 µg/mL in aqueous buffer (pH 7.2–7.4) for cell adhesion or chemotaxis studies. The peptide is soluble at ≥15.53 mg/mL in water, facilitating preparation of stock solutions. DMSO and ethanol stocks can be prepared for specialized assays, with maximum solubility of 48.35 mg/mL and 17.77 mg/mL, respectively. For optimal reproducibility, thaw and dilute just before use; avoid repeated freeze-thaw cycles. APExBIO recommends -20°C storage for the solid peptide and short-term use of prepared solutions.

    To maximize assay sensitivity, it is critical to standardize cell density, incubation time (typically 1–4 hours), and wash steps. Laminin (925-933) is compatible with a wide range of readouts, including microscopy, colorimetric adhesion assays, and migration/chemotaxis chambers. Cross-validation with full-length laminin or alternative ECM peptides is recommended for mechanistic studies.

    Conclusion & Outlook

    Laminin (925-933) represents a rigorously characterized, chemically defined peptide tool for modulating cell adhesion and migration in research settings. Its specificity for the laminin receptor and reproducible activity in standard cell lines make it a reference standard for basement membrane protein research and extracellular matrix signaling studies. As demonstrated in recent benchmarking and translational workflows, Laminin (925-933) outperforms undefined ECM fragments in assay reproducibility and mechanistic clarity. Ongoing research continues to expand its roles in cancer metastasis inhibition and neurobiology, with potential applications in biomarker discovery and disease modeling (McGeachan et al., 2025).

    For more on validated protocols, see Scenario-Driven Solutions in Cell Assays with Laminin (925-933). This article provides an updated, evidence-driven synthesis of Laminin (925-933) benchmarks and workflow integration strategies for researchers seeking robust, translationally relevant outcomes.